175250 — Icure Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩77bn
- KR₩98bn
- KR₩69bn
- 18
- 29
- 59
- 25
Annual cashflow statement for Icure Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12,150 | -38,384 | -42,549 | -32,299 | 24.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1,065 | 12,470 | 18,071 | 11,959 | -18,675 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6,081 | -7,912 | 5,142 | -2,093 | -7,113 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12,403 | -26,186 | -11,282 | -13,519 | -17,054 |
| Capital Expenditures | -27,263 | -6,707 | -5,965 | -2,627 | -2,511 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 33,297 | -13,611 | 8,197 | 5,674 | 64,496 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6,034 | -20,318 | 2,232 | 3,047 | 61,985 |
| Financing Cash Flow Items | 386 | 3,605 | 33,727 | -26.1 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4,295 | 58,398 | 41,813 | -33,764 | -34,078 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2,075 | 11,893 | 32,763 | -44,237 | 10,853 |